# A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis

> **NCT00393146** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 57 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** GW856553

## Key facts

- **NCT ID:** NCT00393146
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00393146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00393146, "A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00393146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*